InnoCan Pharma Corporation (INNO.CN)
Develops CBD-based drugs and topical treatments for pain, skin conditions, and other health issues
2.18-0.26%Consumer Defensive
StockGlow Score
Bearish
BearishBullish
1 year ago-86.0%
The outlook
INNO.CN trades at $2.18, well below both its 50- and 200-day moving averages and sits near the bottom of its 52-week range. Analyst coverage appears thin or unavailable. The overall data lean is bearish.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range10% of the way from its 52-week low to high
Market cap
$9.8M
52-wk high
21.00
52-wk low
0.00
50-day avg
3.32
200-day avg
7.48
Trailing P/E
—